PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFcm
Fcm
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
163 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Iron deficienciesD000090463——171716344
Iron-deficiency anemiaD018798HP_0001891D50161715342
AnemiaD000740HP_0001903D64.914208437
InfectionsD007239EFO_0000544—14517934
Urinary tract infectionsD014552EFO_0003103N39.016515732
Communicable diseasesD003141———2412623
Heart failureD006333HP_0001635I50——17513
Deficiency diseasesD003677EFO_1001067E63—172111
PneumoniaD011014EFO_0003106—12—137
CystitisD003556EFO_1000025N30——1247
Show 41 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LeukemiaD007938—C95—61—29
Lymphoid leukemiaD007945—C91—51—17
Chronic renal insufficiencyD051436—N18——4—15
Kidney diseasesD007674EFO_0003086N08——4—15
HemorrhageD006470MP_0001914R58——1—23
B-cell chronic lymphocytic leukemiaD015451—C91.1—21——3
Uterine hemorrhageD014592———12——3
LymphomaD008223—C85.9——1—12
Follicular lymphomaD008224—C82——1—12
NeutropeniaD009503—D70——1—12
Show 11 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SyndromeD013577———2——24
Precursor cell lymphoblastic leukemia-lymphomaD054198———3——14
Bacterial pneumoniaD018410EFO_1001272J15.9—2——13
Restless legs syndromeD012148EFO_0004270G25.81—3———3
Psychomotor agitationD011595———3———3
AppendicitisD001064EFO_0007149K37—2———2
ToxemiaD014115———1——12
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.9—1——12
Lung diseasesD008171HP_0002088J98.4—1——12
Obstructive lung diseasesD008173HP_0006536——1——12
Show 14 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OsteomyelitisD010019EFO_0003102M861———12
Multiple drug resistanceD018432——1———12
Pseudomonas infectionsD011552EFO_0001076A41.521————1
Disease resistanceD060467——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Circulating neoplastic cellsD009360——————77
PainD010146EFO_0003843R52————33
Cardiac arrhythmiasD001145EFO_0004269I49.9————33
HypertensionD006973EFO_0000537I10————22
MenorrhagiaD008595EFO_0003945N92.0————22
Hemophilia aD006467EFO_0007267D66————22
HyperaldosteronismD006929HP_0011736E26————22
Pulmonary arterial hypertensionD000081029——————22
HypokalemiaD007008HP_0002900E87.6————22
Sleep initiation and maintenance disordersD007319—F51.01————22
Show 84 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification—
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use